These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 20128603)
1. Structure of human G protein-coupled receptor kinase 2 in complex with the kinase inhibitor balanol. Tesmer JJ; Tesmer VM; Lodowski DT; Steinhagen H; Huber J J Med Chem; 2010 Feb; 53(4):1867-70. PubMed ID: 20128603 [TBL] [Abstract][Full Text] [Related]
2. Heterotrimeric G protein beta1gamma2 subunits change orientation upon complex formation with G protein-coupled receptor kinase 2 (GRK2) on a model membrane. Boughton AP; Yang P; Tesmer VM; Ding B; Tesmer JJ; Chen Z Proc Natl Acad Sci U S A; 2011 Sep; 108(37):E667-73. PubMed ID: 21876134 [TBL] [Abstract][Full Text] [Related]
3. The role of G beta gamma and domain interfaces in the activation of G protein-coupled receptor kinase 2. Lodowski DT; Barnhill JF; Pyskadlo RM; Ghirlando R; Sterne-Marr R; Tesmer JJ Biochemistry; 2005 May; 44(18):6958-70. PubMed ID: 15865441 [TBL] [Abstract][Full Text] [Related]
4. Balanol analogues probe specificity determinants and the conformational malleability of the cyclic 3',5'-adenosine monophosphate-dependent protein kinase catalytic subunit. Akamine P; Madhusudan ; Brunton LL; Ou HD; Canaves JM; Xuong NH; Taylor SS Biochemistry; 2004 Jan; 43(1):85-96. PubMed ID: 14705934 [TBL] [Abstract][Full Text] [Related]
6. Effect of Lipid Composition on the Membrane Orientation of the G Protein-Coupled Receptor Kinase 2-Gβ1γ2 Complex. Yang P; Homan KT; Li Y; Cruz-Rodríguez O; Tesmer JJ; Chen Z Biochemistry; 2016 May; 55(20):2841-8. PubMed ID: 27088923 [TBL] [Abstract][Full Text] [Related]
8. Keeping G proteins at bay: a complex between G protein-coupled receptor kinase 2 and Gbetagamma. Lodowski DT; Pitcher JA; Capel WD; Lefkowitz RJ; Tesmer JJ Science; 2003 May; 300(5623):1256-62. PubMed ID: 12764189 [TBL] [Abstract][Full Text] [Related]
9. Snapshot of activated G proteins at the membrane: the Galphaq-GRK2-Gbetagamma complex. Tesmer VM; Kawano T; Shankaranarayanan A; Kozasa T; Tesmer JJ Science; 2005 Dec; 310(5754):1686-90. PubMed ID: 16339447 [TBL] [Abstract][Full Text] [Related]
10. Differential and selective inhibition of protein kinase A and protein kinase C in intact cells by balanol congeners. Gustafsson AB; Brunton LL Mol Pharmacol; 1999 Aug; 56(2):377-82. PubMed ID: 10419557 [TBL] [Abstract][Full Text] [Related]
11. Molecular design and biological activity of potent and selective protein kinase inhibitors related to balanol. Koide K; Bunnage ME; Gomez Paloma L; Kanter JR; Taylor SS; Brunton LL; Nicolaou KC Chem Biol; 1995 Sep; 2(9):601-8. PubMed ID: 9383464 [TBL] [Abstract][Full Text] [Related]
12. G protein γ (Gγ) subtype dependent targeting of GRK2 to M3 receptor by Gβγ. Samaradivakara S; Kankanamge D; Senarath K; Ratnayake K; Karunarathne A Biochem Biophys Res Commun; 2018 Sep; 503(1):165-170. PubMed ID: 29864421 [TBL] [Abstract][Full Text] [Related]
13. Exploration of charge states of balanol analogues acting as ATP-competitive inhibitors in kinases. Hardianto A; Yusuf M; Liu F; Ranganathan S BMC Bioinformatics; 2017 Dec; 18(Suppl 16):572. PubMed ID: 29297286 [TBL] [Abstract][Full Text] [Related]
14. Computational analysis of PKA-balanol interactions. Wong CF; Hünenberger PH; Akamine P; Narayana N; Diller T; McCammon JA; Taylor S; Xuong NH J Med Chem; 2001 May; 44(10):1530-9. PubMed ID: 11334563 [TBL] [Abstract][Full Text] [Related]
15. Rational design of a selective covalent modifier of G protein βγ subunits. Dessal AL; Prades R; Giralt E; Smrcka AV Mol Pharmacol; 2011 Jan; 79(1):24-33. PubMed ID: 20881007 [TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the potent natural product inhibitor balanol in complex with the catalytic subunit of cAMP-dependent protein kinase. Narayana N; Diller TC; Koide K; Bunnage ME; Nicolaou KC; Brunton LL; Xuong NH; Ten Eyck LF; Taylor SS Biochemistry; 1999 Feb; 38(8):2367-76. PubMed ID: 10029530 [TBL] [Abstract][Full Text] [Related]
17. Structural and functional analysis of g protein-coupled receptor kinase inhibition by paroxetine and a rationally designed analog. Homan KT; Wu E; Wilson MW; Singh P; Larsen SD; Tesmer JJ Mol Pharmacol; 2014 Feb; 85(2):237-48. PubMed ID: 24220010 [TBL] [Abstract][Full Text] [Related]
18. The Protein kinase inhibitor balanol: structure-activity relationships and structure-based computational studies. Pande V; Ramos MJ; Gago F Anticancer Agents Med Chem; 2008 Aug; 8(6):638-45. PubMed ID: 18690827 [TBL] [Abstract][Full Text] [Related]
19. Structural basis for selective inhibition of human PKG Iα by the balanol-like compound N46. Qin L; Sankaran B; Aminzai S; Casteel DE; Kim C J Biol Chem; 2018 Jul; 293(28):10985-10992. PubMed ID: 29769318 [TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of P-Rex1 by the cyclic AMP-dependent protein kinase inhibits the phosphatidylinositiol (3,4,5)-trisphosphate and Gbetagamma-mediated regulation of its activity. Mayeenuddin LH; Garrison JC J Biol Chem; 2006 Jan; 281(4):1921-8. PubMed ID: 16301320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]